Greg Bisconti |
SAN DIEGO, CA – With incredible life science/biotech growth in San Diego and throughout the United States, JLL announced that 28-year industry veteran Greg Bisconti has joined the firm as San Diego Life Science Tenant Rep Lead and Executive Managing Director.
Based in JLL’s San Diego, California office,
Bisconti will specialize exclusively in working with life sciences companies on
their real estate and facility needs, both regionally and globally.
He will also
work with JLL leadership in expanding and enhancing a National Life Sciences
Tenant Representation Group.
Chad Urie |
This
partnership builds upon JLL’s best-in-class team focused exclusively on life
sciences occupier and investor clients’ unique needs.
Collectively,
the JLL San Diego team will have represented more life sciences transactions in
the last five years than all regional brokerage firms combined.
Peter Belisle |
"Greg’s
expertise, reputation and passion for helping life sciences companies make him
the perfect candidate to help us service and advocate for the specialized needs
of the industry.
"We are
confident that he will be a valued team member of our team locally, regionally
and nationally."
Grant Schoneman |
Prior to joining JLL, Bisconti served as Vice Chairman and National Life Sciences Practice Group Leader at an international commercial real estate firm.
“Our clients
are getting more sophisticated in their analysis of where and why they do
business,” said Urie, JLL Executive Managing Director.
“Life sciences
is a global game needing a global game plan. Our JLL Life Sciences team strives
to be a consultative partner for clients from early stages of R&D to global
headquarters to sophisticated cGMP manufacturing facilities."
For further information, please visit jll.com.
CONTACT:
David Ebeling
Ebeling Communications
949.861.8351
949.278.7851 (Cell)
Member of the National Association of Real
Estate Editors (NAREE)
“PR Strategist for the Commercial Real
Estate Industry: I do what I love and love what I do.”
No comments:
Post a Comment